Data Query
PBE
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Asset Value: | Change: | Change: |
USD 29.67 | USD 0.32 | 1.09% |
| Price | Change: | Change: |
USD 29.73 | USD 0.38 | 1.29% |
The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Holdings
| Top 10 Holdings | |
| Regeneron Pharmaceuticals, Inc. | 5.95% |
| Biogen Idec Inc | 5.91% |
| Life Technologies Corp | 5.62% |
| Amgen Inc | 5.33% |
| Gilead Sciences Inc | 5.30% |
| Sigma-Aldrich Corporation | 4.58% |
| Waters Corporation | 4.43% |
| NPS Pharmaceuticals Inc | 4.16% |
| Pharmacyclics, Inc. | 4.00% |
| Isis Pharmaceuticals | 3.71% |
| Weighting | 48.99% |
| As of 04/30/2013 | |
Holdings - Country Allocation |
Download Adobe Flash Player to view this page
| Holdings - Sector Breakdowns |
Download Adobe Flash Player to view this page
Historical NAV Performance (%)
1-Day | 1-Week | 1-Mo | 3-Mo | YTD | 1-Yr |
1.09 | 2.42 | 7.93 | 14.11 | 23.92 | 27.31 |
| Cumulative | |||||
2012 | 2011 | 2010 | 2009 | 3 Yr* | 5 Yr* |
13.84 | -8.36 | 31.47 | 21.92 | 12.85 | 9.82 |
| Annual/Annualized | |||||
Portfolio & Management
| Fundamentals | |
| Mean Market Cap: | 5,158.48 |
| P/E Ratio: | 22.09 |
| P/B Ratio: | 4.60 |
| Dividend Yield (% p.a): | 0.00 |
| Sharpe Ratio 3Yr: | 0.71 |
| r-Squared (3 Yr): | 71.41 |
| Std Dev 3 Year: | 19.48 |
| Alpha: | 3.63 |
| Beta: | 0.98 |
| Dividend Frequency: | Quarterly |
| Portfolio Characteristics | |
| Assets Under Management: | 154,040,171 |
| Exp Ratio: | 0.63 |
| Number of Holdings: | 31 |
| Management | |
| Issuing Company: | |
| Inc Date: | 2005-06-23 |
| Trading Symbols: | PBE |
| Trading & Liquidity | |
| Spread: | 0.035 |
| % Spread: | 0.0012 |
| Average Daily Dollar Volume: | 987,737 |
| Average Daily Share Volume: | 33,469 |
Related Articles
| Related Articles | |
The content on IndexUniverse.com and related sites is for informational purposes only. It is not designed to be used by investors in making specific investment decisions. The content is not intended as advice or recommendation.
© 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
